Cardiol Therapeutics Inc. Class A Common Shares CRDL
i
Market datapartial · fetched 2026-11-07T08:06:56.402Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T22:03:37.543876966Z
FundamentalsAlpha Vantage · unavailable
Cardiol Therapeutics Inc. Class A Common Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 1.72 | 381.1% | 87.8% | |||
| 35Δ | 1.64 | 416.6% | 83.6% | |||
| 40Δ | 1.56 | 452.2% | 79.4% | |||
| 45Δ | 1.48 | 487.7% | 75.2% | |||
| 50Δ | 1.40 | 523.2% | 71.0% | |||
| 55Δ | 1.32 | 558.7% | 66.8% | |||
| 60Δ | 1.24 | 594.2% | 62.6% | |||
| 65Δ | 1.16 | 629.7% | 58.4% | |||
| 70Δ | 1.08 | 665.2% | 54.2% | 2.01 | 397.4% | 9.9% |
| 75Δ | 1.00 | 700.7% | 50.0% | 2.22 | 388.4% | 7.8% |
| 80Δ | 0.81 | 637.1% | 34.9% | 2.43 | 379.4% | 5.7% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 1.72
- IV
- 381.1%
- B/E move
- 87.8%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 1.64
- IV
- 416.6%
- B/E move
- 83.6%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 1.56
- IV
- 452.2%
- B/E move
- 79.4%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 1.48
- IV
- 487.7%
- B/E move
- 75.2%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 1.40
- IV
- 523.2%
- B/E move
- 71.0%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 1.32
- IV
- 558.7%
- B/E move
- 66.8%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 1.24
- IV
- 594.2%
- B/E move
- 62.6%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 1.16
- IV
- 629.7%
- B/E move
- 58.4%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 1.08
- IV
- 665.2%
- B/E move
- 54.2%
- Pseudo strike
- 2.01
- IV
- 397.4%
- B/E move
- 9.9%
75Δ
- Pseudo strike
- 1.00
- IV
- 700.7%
- B/E move
- 50.0%
- Pseudo strike
- 2.22
- IV
- 388.4%
- B/E move
- 7.8%
80Δ
- Pseudo strike
- 0.81
- IV
- 637.1%
- B/E move
- 34.9%
- Pseudo strike
- 2.43
- IV
- 379.4%
- B/E move
- 5.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 237.53% |
Drug Manufacturers - Specialty & Generic
CRON
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
More →DERM
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
More →EBS
Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address…
More →ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in…
More →EOLS
Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in…
More →ETON
Description unavailable
More →